Evidence map›Paper›PMID 37529348›Full record

ArticleScience, technology & human values2023

Co-producing Human and Animal Experimental Subjects: Exploring the Views of UK COVID-19 Vaccine Trial Participants on Animal Testing.

Samantha Vanderslott, Alexandra Palmer, Tonia Thomas, Beth Greenhough, Arabella Stuart, John A Henry, Marcus English, Rebecca de Water Naude, Maia Patrick-Smith, Naomi Douglas and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science, technology & human values, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Samantha VanderslottOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Alexandra PalmerSchool of Geography and the Environment, Oxford University Centre for the Environment, University of Oxford, United Kingdom.ORCID https://orcid.org/0000-0001-5273-4813
Tonia ThomasOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Beth GreenhoughSchool of Geography and the Environment, Oxford University Centre for the Environment, University of Oxford, United Kingdom.
Arabella StuartOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
John A HenryOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.ORCID https://orcid.org/0000-0002-7650-0963
Marcus EnglishOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Rebecca de Water NaudeOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Maia Patrick-SmithOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Naomi DouglasOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Maria MooreOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Susanne H HodgsonJenner Institute, Nuffield Department of Medicine, University of Oxford, United Kingdom.
Katherine R W EmaryOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Andrew J PollardOxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.

Funding

Wellcome Trust 205393/Z/16/Z
6 · The paper itself

Abstract

Preclinical (animal) testing and human testing of drugs and vaccines are rarely considered by social scientists side by side. Where this is done, it is typically for theoretically exploring the ethics of the two situations to compare relative treatment. In contrast, we empirically explore how human clinical trial participants understand the role of animal test subjects in vaccine development. Furthermore, social science research has only concentrated on broad public opinion and the views of patients about animal research, whereas we explore the views of a public group particularly implicated in pharmaceutical development:

Indexed as

animal researchclinical trialco-productionCOVID-19vaccine

Identifiers

PMID37529348
PMCPMC10387720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.